Global iPSC Therapy Supply, Demand and Key Producers, 2026-2032
The global iPSC Therapy market size is expected to reach $ 188 million by 2032, rising at a market growth of 11.0% CAGR during the forecast period (2026-2032).
iPSC Therapy (Induced Pluripotent Stem Cell Therapy) is an advanced regenerative medicine technology centered on induced pluripotent stem cells. In this approach, somatic cells such as skin or blood cells are reprogrammed by specific transcription factors to revert to a pluripotent state capable of differentiating into multiple cell types. These iPSCs can then be guided to develop into functional cells such as neurons, cardiomyocytes, retinal cells, or immune cells, which are used to replace or repair damaged tissues. iPSC therapy combines the pluripotency of embryonic stem cells with controllable cell sourcing, thereby avoiding major ethical concerns while enabling both personalized and standardized cell-based therapies. The technology shows significant potential in treating neurodegenerative diseases, cardiovascular disorders, ophthalmic conditions, cancer immunotherapy, and rare diseases. With continuous advances in cellular reprogramming, gene editing, and cell culture technologies, iPSC therapy is gradually transitioning from laboratory research to clinical applications and is becoming a key pillar of regenerative medicine and precision healthcare.
The market for iPSC therapy is driven by rapid advances in regenerative medicine and precision healthcare. The growing prevalence of chronic diseases, neurodegenerative disorders, and rare diseases highlights the limitations of conventional drug therapies in tissue repair and functional recovery, creating demand for cell-based treatments. iPSC technology provides a stable and expandable source of cells, supporting tissue regeneration, immune therapy, and disease modeling. Advances in gene editing and automated cell culture technologies are improving the safety, controllability, and scalability of cell therapy products. In addition, many governments worldwide are actively promoting the development of regenerative medicine through research funding, supportive policies, and industry collaboration, creating favorable conditions for the commercialization of iPSC-based therapies.
Despite its strong potential, iPSC therapy faces several challenges. The processes of cellular reprogramming and differentiation are complex and require strict control of culture conditions, quality assurance systems, and manufacturing standards. Potential risks such as tumorigenicity, immune rejection, and uncertainties regarding long-term therapeutic outcomes remain key concerns in clinical development. Regulatory authorities maintain rigorous approval procedures for cell-based therapies, resulting in long development timelines and high costs. In addition, supply chains for cell preparation, storage, and transportation are still evolving, which may affect the large-scale industrialization of the technology.
Downstream demand mainly comes from hospitals, biotechnology companies, and research institutions. As personalized medicine gains traction, demand for cell therapies targeting neurological disorders, cardiovascular diseases, and ophthalmic conditions continues to increase. iPSC-derived cells are also widely used in disease modeling, drug discovery, and toxicity testing, providing valuable platforms for pharmaceutical research. Healthcare providers and biopharmaceutical companies are increasingly exploring the therapeutic potential of cell-based treatments for complex diseases, driving continued growth in clinical research and industry partnerships. As manufacturing technologies mature and standardization improves, demand for iPSC therapy in both clinical treatment and drug development is expected to expand further.
The upstream segment of the iPSC therapy industry primarily includes cell culture media, growth factors, gene reprogramming vectors, and cell culture consumables. High-quality culture media and growth factors provide the necessary microenvironment for cell proliferation and differentiation and are essential components of cell production. Gene reprogramming tools, often based on viral or non-viral vector technologies, are used to introduce transcription factors into somatic cells to induce pluripotency. The production process also requires a large number of high-standard laboratory consumables such as culture dishes, flasks, and sterile filtration systems to maintain stable manufacturing conditions and consistent cell quality. With ongoing advancements in cell manufacturing technologies, automated culture equipment and advanced biomaterials are becoming increasingly important upstream components, supporting the technological progress of the entire cell therapy industry.
This report studies the global iPSC Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for iPSC Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of iPSC Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global iPSC Therapy total market, 2021-2032, (USD Million)
Global iPSC Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: iPSC Therapy total market, key domestic companies, and share, (USD Million)
Global iPSC Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global iPSC Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global iPSC Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global iPSC Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fujifilm, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL, Thermo Fisher Scientific, Sartorius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world iPSC Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global iPSC Therapy Market, By Region:
1. How big is the global iPSC Therapy market?
2. What is the demand of the global iPSC Therapy market?
3. What is the year over year growth of the global iPSC Therapy market?
4. What is the total value of the global iPSC Therapy market?
5. Who are the Major Players in the global iPSC Therapy market?
6. What are the growth factors driving the market demand?
iPSC Therapy (Induced Pluripotent Stem Cell Therapy) is an advanced regenerative medicine technology centered on induced pluripotent stem cells. In this approach, somatic cells such as skin or blood cells are reprogrammed by specific transcription factors to revert to a pluripotent state capable of differentiating into multiple cell types. These iPSCs can then be guided to develop into functional cells such as neurons, cardiomyocytes, retinal cells, or immune cells, which are used to replace or repair damaged tissues. iPSC therapy combines the pluripotency of embryonic stem cells with controllable cell sourcing, thereby avoiding major ethical concerns while enabling both personalized and standardized cell-based therapies. The technology shows significant potential in treating neurodegenerative diseases, cardiovascular disorders, ophthalmic conditions, cancer immunotherapy, and rare diseases. With continuous advances in cellular reprogramming, gene editing, and cell culture technologies, iPSC therapy is gradually transitioning from laboratory research to clinical applications and is becoming a key pillar of regenerative medicine and precision healthcare.
The market for iPSC therapy is driven by rapid advances in regenerative medicine and precision healthcare. The growing prevalence of chronic diseases, neurodegenerative disorders, and rare diseases highlights the limitations of conventional drug therapies in tissue repair and functional recovery, creating demand for cell-based treatments. iPSC technology provides a stable and expandable source of cells, supporting tissue regeneration, immune therapy, and disease modeling. Advances in gene editing and automated cell culture technologies are improving the safety, controllability, and scalability of cell therapy products. In addition, many governments worldwide are actively promoting the development of regenerative medicine through research funding, supportive policies, and industry collaboration, creating favorable conditions for the commercialization of iPSC-based therapies.
Despite its strong potential, iPSC therapy faces several challenges. The processes of cellular reprogramming and differentiation are complex and require strict control of culture conditions, quality assurance systems, and manufacturing standards. Potential risks such as tumorigenicity, immune rejection, and uncertainties regarding long-term therapeutic outcomes remain key concerns in clinical development. Regulatory authorities maintain rigorous approval procedures for cell-based therapies, resulting in long development timelines and high costs. In addition, supply chains for cell preparation, storage, and transportation are still evolving, which may affect the large-scale industrialization of the technology.
Downstream demand mainly comes from hospitals, biotechnology companies, and research institutions. As personalized medicine gains traction, demand for cell therapies targeting neurological disorders, cardiovascular diseases, and ophthalmic conditions continues to increase. iPSC-derived cells are also widely used in disease modeling, drug discovery, and toxicity testing, providing valuable platforms for pharmaceutical research. Healthcare providers and biopharmaceutical companies are increasingly exploring the therapeutic potential of cell-based treatments for complex diseases, driving continued growth in clinical research and industry partnerships. As manufacturing technologies mature and standardization improves, demand for iPSC therapy in both clinical treatment and drug development is expected to expand further.
The upstream segment of the iPSC therapy industry primarily includes cell culture media, growth factors, gene reprogramming vectors, and cell culture consumables. High-quality culture media and growth factors provide the necessary microenvironment for cell proliferation and differentiation and are essential components of cell production. Gene reprogramming tools, often based on viral or non-viral vector technologies, are used to introduce transcription factors into somatic cells to induce pluripotency. The production process also requires a large number of high-standard laboratory consumables such as culture dishes, flasks, and sterile filtration systems to maintain stable manufacturing conditions and consistent cell quality. With ongoing advancements in cell manufacturing technologies, automated culture equipment and advanced biomaterials are becoming increasingly important upstream components, supporting the technological progress of the entire cell therapy industry.
This report studies the global iPSC Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for iPSC Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of iPSC Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global iPSC Therapy total market, 2021-2032, (USD Million)
Global iPSC Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: iPSC Therapy total market, key domestic companies, and share, (USD Million)
Global iPSC Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global iPSC Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global iPSC Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global iPSC Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fujifilm, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL, Thermo Fisher Scientific, Sartorius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world iPSC Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global iPSC Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Human iPSCs
- Mouse iPSCs
- Hospitals
- Biotech Firms
- Research Institutes
- Neural Cells
- Cardiac Cells
- Retinal Cells
- Immune Cells
- Academic Research
- Drug Development and Discovery
- Toxicity Screening
- Regenerative Medicine
- Others
- Fujifilm
- Ncardia
- Sumitomo Dainippon Pharma
- Astellas Pharma Inc
- Fate Therapeutics, Inc
- Pluricell Biotech
- Cell Inspire Biotechnology
- ReproCELL
- Thermo Fisher Scientific
- Sartorius
- Bio-techne
1. How big is the global iPSC Therapy market?
2. What is the demand of the global iPSC Therapy market?
3. What is the year over year growth of the global iPSC Therapy market?
4. What is the total value of the global iPSC Therapy market?
5. Who are the Major Players in the global iPSC Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 iPSC Therapy Introduction
1.2 World iPSC Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World iPSC Therapy Total Market by Region (by Headquarter Location)
1.3.1 World iPSC Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company iPSC Therapy Revenue (2021-2032)
1.3.3 China Based Company iPSC Therapy Revenue (2021-2032)
1.3.4 Europe Based Company iPSC Therapy Revenue (2021-2032)
1.3.5 Japan Based Company iPSC Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company iPSC Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company iPSC Therapy Revenue (2021-2032)
1.3.8 India Based Company iPSC Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 iPSC Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World iPSC Therapy Consumption Value (2021-2032)
2.2 World iPSC Therapy Consumption Value by Region
2.2.1 World iPSC Therapy Consumption Value by Region (2021-2026)
2.2.2 World iPSC Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States iPSC Therapy Consumption Value (2021-2032)
2.4 China iPSC Therapy Consumption Value (2021-2032)
2.5 Europe iPSC Therapy Consumption Value (2021-2032)
2.6 Japan iPSC Therapy Consumption Value (2021-2032)
2.7 South Korea iPSC Therapy Consumption Value (2021-2032)
2.8 ASEAN iPSC Therapy Consumption Value (2021-2032)
2.9 India iPSC Therapy Consumption Value (2021-2032)
3 WORLD IPSC THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World iPSC Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global iPSC Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for iPSC Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for iPSC Therapy in 2025
3.3 iPSC Therapy Company Evaluation Quadrant
3.4 iPSC Therapy Market: Overall Company Footprint Analysis
3.4.1 iPSC Therapy Market: Region Footprint
3.4.2 iPSC Therapy Market: Company Product Type Footprint
3.4.3 iPSC Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: iPSC Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: iPSC Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: iPSC Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: iPSC Therapy Consumption Value Comparison
4.2.1 United States VS China: iPSC Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: iPSC Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based iPSC Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based iPSC Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies iPSC Therapy Revenue, (2021-2026)
4.4 China Based Companies iPSC Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based iPSC Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies iPSC Therapy Revenue, (2021-2026)
4.5 Rest of World Based iPSC Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based iPSC Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies iPSC Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World iPSC Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Human iPSCs
5.2.2 Mouse iPSCs
5.3 Market Segment by Type
5.3.1 World iPSC Therapy Market Size by Type (2021-2026)
5.3.2 World iPSC Therapy Market Size by Type (2027-2032)
5.3.3 World iPSC Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY END USER
6.1 World iPSC Therapy Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Hospitals
6.2.2 Biotech Firms
6.2.3 Research Institutes
6.3 Market Segment by End User
6.3.1 World iPSC Therapy Market Size by End User (2021-2026)
6.3.2 World iPSC Therapy Market Size by End User (2027-2032)
6.3.3 World iPSC Therapy Market Size Market Share by End User (2027-2032)
7 MARKET ANALYSIS BY CELL TYPE
7.1 World iPSC Therapy Market Size Overview by Cell Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Cell Type
7.2.1 Neural Cells
7.2.2 Cardiac Cells
7.2.3 Retinal Cells
7.2.4 Immune Cells
7.3 Market Segment by Cell Type
7.3.1 World iPSC Therapy Market Size by Cell Type (2021-2026)
7.3.2 World iPSC Therapy Market Size by Cell Type (2027-2032)
7.3.3 World iPSC Therapy Market Size Market Share by Cell Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World iPSC Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Academic Research
8.2.2 Drug Development and Discovery
8.2.3 Toxicity Screening
8.2.4 Regenerative Medicine
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World iPSC Therapy Market Size by Application (2021-2026)
8.3.2 World iPSC Therapy Market Size by Application (2027-2032)
8.3.3 World iPSC Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Fujifilm
9.1.1 Fujifilm Details
9.1.2 Fujifilm Major Business
9.1.3 Fujifilm iPSC Therapy Product and Services
9.1.4 Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Fujifilm Recent Developments/Updates
9.1.6 Fujifilm Competitive Strengths & Weaknesses
9.2 Ncardia
9.2.1 Ncardia Details
9.2.2 Ncardia Major Business
9.2.3 Ncardia iPSC Therapy Product and Services
9.2.4 Ncardia iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Ncardia Recent Developments/Updates
9.2.6 Ncardia Competitive Strengths & Weaknesses
9.3 Sumitomo Dainippon Pharma
9.3.1 Sumitomo Dainippon Pharma Details
9.3.2 Sumitomo Dainippon Pharma Major Business
9.3.3 Sumitomo Dainippon Pharma iPSC Therapy Product and Services
9.3.4 Sumitomo Dainippon Pharma iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sumitomo Dainippon Pharma Recent Developments/Updates
9.3.6 Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
9.4 Astellas Pharma Inc
9.4.1 Astellas Pharma Inc Details
9.4.2 Astellas Pharma Inc Major Business
9.4.3 Astellas Pharma Inc iPSC Therapy Product and Services
9.4.4 Astellas Pharma Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Astellas Pharma Inc Recent Developments/Updates
9.4.6 Astellas Pharma Inc Competitive Strengths & Weaknesses
9.5 Fate Therapeutics, Inc
9.5.1 Fate Therapeutics, Inc Details
9.5.2 Fate Therapeutics, Inc Major Business
9.5.3 Fate Therapeutics, Inc iPSC Therapy Product and Services
9.5.4 Fate Therapeutics, Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Fate Therapeutics, Inc Recent Developments/Updates
9.5.6 Fate Therapeutics, Inc Competitive Strengths & Weaknesses
9.6 Pluricell Biotech
9.6.1 Pluricell Biotech Details
9.6.2 Pluricell Biotech Major Business
9.6.3 Pluricell Biotech iPSC Therapy Product and Services
9.6.4 Pluricell Biotech iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Pluricell Biotech Recent Developments/Updates
9.6.6 Pluricell Biotech Competitive Strengths & Weaknesses
9.7 Cell Inspire Biotechnology
9.7.1 Cell Inspire Biotechnology Details
9.7.2 Cell Inspire Biotechnology Major Business
9.7.3 Cell Inspire Biotechnology iPSC Therapy Product and Services
9.7.4 Cell Inspire Biotechnology iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Cell Inspire Biotechnology Recent Developments/Updates
9.7.6 Cell Inspire Biotechnology Competitive Strengths & Weaknesses
9.8 ReproCELL
9.8.1 ReproCELL Details
9.8.2 ReproCELL Major Business
9.8.3 ReproCELL iPSC Therapy Product and Services
9.8.4 ReproCELL iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ReproCELL Recent Developments/Updates
9.8.6 ReproCELL Competitive Strengths & Weaknesses
9.9 Thermo Fisher Scientific
9.9.1 Thermo Fisher Scientific Details
9.9.2 Thermo Fisher Scientific Major Business
9.9.3 Thermo Fisher Scientific iPSC Therapy Product and Services
9.9.4 Thermo Fisher Scientific iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Thermo Fisher Scientific Recent Developments/Updates
9.9.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.10 Sartorius
9.10.1 Sartorius Details
9.10.2 Sartorius Major Business
9.10.3 Sartorius iPSC Therapy Product and Services
9.10.4 Sartorius iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Sartorius Recent Developments/Updates
9.10.6 Sartorius Competitive Strengths & Weaknesses
9.11 Bio-techne
9.11.1 Bio-techne Details
9.11.2 Bio-techne Major Business
9.11.3 Bio-techne iPSC Therapy Product and Services
9.11.4 Bio-techne iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Bio-techne Recent Developments/Updates
9.11.6 Bio-techne Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 iPSC Therapy Industry Chain
10.2 iPSC Therapy Upstream Analysis
10.3 iPSC Therapy Midstream Analysis
10.4 iPSC Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 iPSC Therapy Introduction
1.2 World iPSC Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World iPSC Therapy Total Market by Region (by Headquarter Location)
1.3.1 World iPSC Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company iPSC Therapy Revenue (2021-2032)
1.3.3 China Based Company iPSC Therapy Revenue (2021-2032)
1.3.4 Europe Based Company iPSC Therapy Revenue (2021-2032)
1.3.5 Japan Based Company iPSC Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company iPSC Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company iPSC Therapy Revenue (2021-2032)
1.3.8 India Based Company iPSC Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 iPSC Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World iPSC Therapy Consumption Value (2021-2032)
2.2 World iPSC Therapy Consumption Value by Region
2.2.1 World iPSC Therapy Consumption Value by Region (2021-2026)
2.2.2 World iPSC Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States iPSC Therapy Consumption Value (2021-2032)
2.4 China iPSC Therapy Consumption Value (2021-2032)
2.5 Europe iPSC Therapy Consumption Value (2021-2032)
2.6 Japan iPSC Therapy Consumption Value (2021-2032)
2.7 South Korea iPSC Therapy Consumption Value (2021-2032)
2.8 ASEAN iPSC Therapy Consumption Value (2021-2032)
2.9 India iPSC Therapy Consumption Value (2021-2032)
3 WORLD IPSC THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World iPSC Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global iPSC Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for iPSC Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for iPSC Therapy in 2025
3.3 iPSC Therapy Company Evaluation Quadrant
3.4 iPSC Therapy Market: Overall Company Footprint Analysis
3.4.1 iPSC Therapy Market: Region Footprint
3.4.2 iPSC Therapy Market: Company Product Type Footprint
3.4.3 iPSC Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: iPSC Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: iPSC Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: iPSC Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: iPSC Therapy Consumption Value Comparison
4.2.1 United States VS China: iPSC Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: iPSC Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based iPSC Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based iPSC Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies iPSC Therapy Revenue, (2021-2026)
4.4 China Based Companies iPSC Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based iPSC Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies iPSC Therapy Revenue, (2021-2026)
4.5 Rest of World Based iPSC Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based iPSC Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies iPSC Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World iPSC Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Human iPSCs
5.2.2 Mouse iPSCs
5.3 Market Segment by Type
5.3.1 World iPSC Therapy Market Size by Type (2021-2026)
5.3.2 World iPSC Therapy Market Size by Type (2027-2032)
5.3.3 World iPSC Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY END USER
6.1 World iPSC Therapy Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Hospitals
6.2.2 Biotech Firms
6.2.3 Research Institutes
6.3 Market Segment by End User
6.3.1 World iPSC Therapy Market Size by End User (2021-2026)
6.3.2 World iPSC Therapy Market Size by End User (2027-2032)
6.3.3 World iPSC Therapy Market Size Market Share by End User (2027-2032)
7 MARKET ANALYSIS BY CELL TYPE
7.1 World iPSC Therapy Market Size Overview by Cell Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Cell Type
7.2.1 Neural Cells
7.2.2 Cardiac Cells
7.2.3 Retinal Cells
7.2.4 Immune Cells
7.3 Market Segment by Cell Type
7.3.1 World iPSC Therapy Market Size by Cell Type (2021-2026)
7.3.2 World iPSC Therapy Market Size by Cell Type (2027-2032)
7.3.3 World iPSC Therapy Market Size Market Share by Cell Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World iPSC Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Academic Research
8.2.2 Drug Development and Discovery
8.2.3 Toxicity Screening
8.2.4 Regenerative Medicine
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World iPSC Therapy Market Size by Application (2021-2026)
8.3.2 World iPSC Therapy Market Size by Application (2027-2032)
8.3.3 World iPSC Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Fujifilm
9.1.1 Fujifilm Details
9.1.2 Fujifilm Major Business
9.1.3 Fujifilm iPSC Therapy Product and Services
9.1.4 Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Fujifilm Recent Developments/Updates
9.1.6 Fujifilm Competitive Strengths & Weaknesses
9.2 Ncardia
9.2.1 Ncardia Details
9.2.2 Ncardia Major Business
9.2.3 Ncardia iPSC Therapy Product and Services
9.2.4 Ncardia iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Ncardia Recent Developments/Updates
9.2.6 Ncardia Competitive Strengths & Weaknesses
9.3 Sumitomo Dainippon Pharma
9.3.1 Sumitomo Dainippon Pharma Details
9.3.2 Sumitomo Dainippon Pharma Major Business
9.3.3 Sumitomo Dainippon Pharma iPSC Therapy Product and Services
9.3.4 Sumitomo Dainippon Pharma iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sumitomo Dainippon Pharma Recent Developments/Updates
9.3.6 Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
9.4 Astellas Pharma Inc
9.4.1 Astellas Pharma Inc Details
9.4.2 Astellas Pharma Inc Major Business
9.4.3 Astellas Pharma Inc iPSC Therapy Product and Services
9.4.4 Astellas Pharma Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Astellas Pharma Inc Recent Developments/Updates
9.4.6 Astellas Pharma Inc Competitive Strengths & Weaknesses
9.5 Fate Therapeutics, Inc
9.5.1 Fate Therapeutics, Inc Details
9.5.2 Fate Therapeutics, Inc Major Business
9.5.3 Fate Therapeutics, Inc iPSC Therapy Product and Services
9.5.4 Fate Therapeutics, Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Fate Therapeutics, Inc Recent Developments/Updates
9.5.6 Fate Therapeutics, Inc Competitive Strengths & Weaknesses
9.6 Pluricell Biotech
9.6.1 Pluricell Biotech Details
9.6.2 Pluricell Biotech Major Business
9.6.3 Pluricell Biotech iPSC Therapy Product and Services
9.6.4 Pluricell Biotech iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Pluricell Biotech Recent Developments/Updates
9.6.6 Pluricell Biotech Competitive Strengths & Weaknesses
9.7 Cell Inspire Biotechnology
9.7.1 Cell Inspire Biotechnology Details
9.7.2 Cell Inspire Biotechnology Major Business
9.7.3 Cell Inspire Biotechnology iPSC Therapy Product and Services
9.7.4 Cell Inspire Biotechnology iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Cell Inspire Biotechnology Recent Developments/Updates
9.7.6 Cell Inspire Biotechnology Competitive Strengths & Weaknesses
9.8 ReproCELL
9.8.1 ReproCELL Details
9.8.2 ReproCELL Major Business
9.8.3 ReproCELL iPSC Therapy Product and Services
9.8.4 ReproCELL iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ReproCELL Recent Developments/Updates
9.8.6 ReproCELL Competitive Strengths & Weaknesses
9.9 Thermo Fisher Scientific
9.9.1 Thermo Fisher Scientific Details
9.9.2 Thermo Fisher Scientific Major Business
9.9.3 Thermo Fisher Scientific iPSC Therapy Product and Services
9.9.4 Thermo Fisher Scientific iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Thermo Fisher Scientific Recent Developments/Updates
9.9.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.10 Sartorius
9.10.1 Sartorius Details
9.10.2 Sartorius Major Business
9.10.3 Sartorius iPSC Therapy Product and Services
9.10.4 Sartorius iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Sartorius Recent Developments/Updates
9.10.6 Sartorius Competitive Strengths & Weaknesses
9.11 Bio-techne
9.11.1 Bio-techne Details
9.11.2 Bio-techne Major Business
9.11.3 Bio-techne iPSC Therapy Product and Services
9.11.4 Bio-techne iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Bio-techne Recent Developments/Updates
9.11.6 Bio-techne Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 iPSC Therapy Industry Chain
10.2 iPSC Therapy Upstream Analysis
10.3 iPSC Therapy Midstream Analysis
10.4 iPSC Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World iPSC Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World iPSC Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World iPSC Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World iPSC Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World iPSC Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World iPSC Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World iPSC Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World iPSC Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World iPSC Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key iPSC Therapy Players in 2025
Table 12. World iPSC Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global iPSC Therapy Company Evaluation Quadrant
Table 14. Head Office of Key iPSC Therapy Players
Table 15. iPSC Therapy Market: Company Product Type Footprint
Table 16. iPSC Therapy Market: Company Product Application Footprint
Table 17. iPSC Therapy Mergers & Acquisitions Activity
Table 18. United States VS China iPSC Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China iPSC Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based iPSC Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies iPSC Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies iPSC Therapy Revenue Market Share (2021-2026)
Table 23. China Based iPSC Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies iPSC Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies iPSC Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based iPSC Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies iPSC Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies iPSC Therapy Revenue Market Share (2021-2026)
Table 29. World iPSC Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World iPSC Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World iPSC Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World iPSC Therapy Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 33. World iPSC Therapy Market Size Value by End User (2021-2026) & (USD Million)
Table 34. World iPSC Therapy Market Size by End User (2027-2032) & (USD Million)
Table 35. World iPSC Therapy Market Size by Cell Type, (USD Million), 2021 & 2025 & 2032
Table 36. World iPSC Therapy Market Size Value by Cell Type (2021-2026) & (USD Million)
Table 37. World iPSC Therapy Market Size by Cell Type (2027-2032) & (USD Million)
Table 38. World iPSC Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World iPSC Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World iPSC Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 42. Fujifilm Major Business
Table 43. Fujifilm iPSC Therapy Product and Services
Table 44. Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Fujifilm Recent Developments/Updates
Table 46. Fujifilm Competitive Strengths & Weaknesses
Table 47. Ncardia Basic Information, Manufacturing Base and Competitors
Table 48. Ncardia Major Business
Table 49. Ncardia iPSC Therapy Product and Services
Table 50. Ncardia iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Ncardia Recent Developments/Updates
Table 52. Ncardia Competitive Strengths & Weaknesses
Table 53. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Sumitomo Dainippon Pharma Major Business
Table 55. Sumitomo Dainippon Pharma iPSC Therapy Product and Services
Table 56. Sumitomo Dainippon Pharma iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 58. Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
Table 59. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 60. Astellas Pharma Inc Major Business
Table 61. Astellas Pharma Inc iPSC Therapy Product and Services
Table 62. Astellas Pharma Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Astellas Pharma Inc Recent Developments/Updates
Table 64. Astellas Pharma Inc Competitive Strengths & Weaknesses
Table 65. Fate Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 66. Fate Therapeutics, Inc Major Business
Table 67. Fate Therapeutics, Inc iPSC Therapy Product and Services
Table 68. Fate Therapeutics, Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Fate Therapeutics, Inc Recent Developments/Updates
Table 70. Fate Therapeutics, Inc Competitive Strengths & Weaknesses
Table 71. Pluricell Biotech Basic Information, Manufacturing Base and Competitors
Table 72. Pluricell Biotech Major Business
Table 73. Pluricell Biotech iPSC Therapy Product and Services
Table 74. Pluricell Biotech iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Pluricell Biotech Recent Developments/Updates
Table 76. Pluricell Biotech Competitive Strengths & Weaknesses
Table 77. Cell Inspire Biotechnology Basic Information, Manufacturing Base and Competitors
Table 78. Cell Inspire Biotechnology Major Business
Table 79. Cell Inspire Biotechnology iPSC Therapy Product and Services
Table 80. Cell Inspire Biotechnology iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Cell Inspire Biotechnology Recent Developments/Updates
Table 82. Cell Inspire Biotechnology Competitive Strengths & Weaknesses
Table 83. ReproCELL Basic Information, Manufacturing Base and Competitors
Table 84. ReproCELL Major Business
Table 85. ReproCELL iPSC Therapy Product and Services
Table 86. ReproCELL iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ReproCELL Recent Developments/Updates
Table 88. ReproCELL Competitive Strengths & Weaknesses
Table 89. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 90. Thermo Fisher Scientific Major Business
Table 91. Thermo Fisher Scientific iPSC Therapy Product and Services
Table 92. Thermo Fisher Scientific iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Thermo Fisher Scientific Recent Developments/Updates
Table 94. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 95. Sartorius Basic Information, Manufacturing Base and Competitors
Table 96. Sartorius Major Business
Table 97. Sartorius iPSC Therapy Product and Services
Table 98. Sartorius iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Sartorius Recent Developments/Updates
Table 100. Sartorius Competitive Strengths & Weaknesses
Table 101. Bio-techne Basic Information, Manufacturing Base and Competitors
Table 102. Bio-techne Major Business
Table 103. Bio-techne iPSC Therapy Product and Services
Table 104. Bio-techne iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Bio-techne Recent Developments/Updates
Table 106. Bio-techne Competitive Strengths & Weaknesses
Table 107. Global Key Players of iPSC Therapy Upstream (Raw Materials)
Table 108. Global iPSC Therapy Typical Customers
Table 1. World iPSC Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World iPSC Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World iPSC Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World iPSC Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World iPSC Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World iPSC Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World iPSC Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World iPSC Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World iPSC Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key iPSC Therapy Players in 2025
Table 12. World iPSC Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global iPSC Therapy Company Evaluation Quadrant
Table 14. Head Office of Key iPSC Therapy Players
Table 15. iPSC Therapy Market: Company Product Type Footprint
Table 16. iPSC Therapy Market: Company Product Application Footprint
Table 17. iPSC Therapy Mergers & Acquisitions Activity
Table 18. United States VS China iPSC Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China iPSC Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based iPSC Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies iPSC Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies iPSC Therapy Revenue Market Share (2021-2026)
Table 23. China Based iPSC Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies iPSC Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies iPSC Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based iPSC Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies iPSC Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies iPSC Therapy Revenue Market Share (2021-2026)
Table 29. World iPSC Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World iPSC Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World iPSC Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World iPSC Therapy Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 33. World iPSC Therapy Market Size Value by End User (2021-2026) & (USD Million)
Table 34. World iPSC Therapy Market Size by End User (2027-2032) & (USD Million)
Table 35. World iPSC Therapy Market Size by Cell Type, (USD Million), 2021 & 2025 & 2032
Table 36. World iPSC Therapy Market Size Value by Cell Type (2021-2026) & (USD Million)
Table 37. World iPSC Therapy Market Size by Cell Type (2027-2032) & (USD Million)
Table 38. World iPSC Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World iPSC Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World iPSC Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 42. Fujifilm Major Business
Table 43. Fujifilm iPSC Therapy Product and Services
Table 44. Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Fujifilm Recent Developments/Updates
Table 46. Fujifilm Competitive Strengths & Weaknesses
Table 47. Ncardia Basic Information, Manufacturing Base and Competitors
Table 48. Ncardia Major Business
Table 49. Ncardia iPSC Therapy Product and Services
Table 50. Ncardia iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Ncardia Recent Developments/Updates
Table 52. Ncardia Competitive Strengths & Weaknesses
Table 53. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Sumitomo Dainippon Pharma Major Business
Table 55. Sumitomo Dainippon Pharma iPSC Therapy Product and Services
Table 56. Sumitomo Dainippon Pharma iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 58. Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
Table 59. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 60. Astellas Pharma Inc Major Business
Table 61. Astellas Pharma Inc iPSC Therapy Product and Services
Table 62. Astellas Pharma Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Astellas Pharma Inc Recent Developments/Updates
Table 64. Astellas Pharma Inc Competitive Strengths & Weaknesses
Table 65. Fate Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 66. Fate Therapeutics, Inc Major Business
Table 67. Fate Therapeutics, Inc iPSC Therapy Product and Services
Table 68. Fate Therapeutics, Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Fate Therapeutics, Inc Recent Developments/Updates
Table 70. Fate Therapeutics, Inc Competitive Strengths & Weaknesses
Table 71. Pluricell Biotech Basic Information, Manufacturing Base and Competitors
Table 72. Pluricell Biotech Major Business
Table 73. Pluricell Biotech iPSC Therapy Product and Services
Table 74. Pluricell Biotech iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Pluricell Biotech Recent Developments/Updates
Table 76. Pluricell Biotech Competitive Strengths & Weaknesses
Table 77. Cell Inspire Biotechnology Basic Information, Manufacturing Base and Competitors
Table 78. Cell Inspire Biotechnology Major Business
Table 79. Cell Inspire Biotechnology iPSC Therapy Product and Services
Table 80. Cell Inspire Biotechnology iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Cell Inspire Biotechnology Recent Developments/Updates
Table 82. Cell Inspire Biotechnology Competitive Strengths & Weaknesses
Table 83. ReproCELL Basic Information, Manufacturing Base and Competitors
Table 84. ReproCELL Major Business
Table 85. ReproCELL iPSC Therapy Product and Services
Table 86. ReproCELL iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ReproCELL Recent Developments/Updates
Table 88. ReproCELL Competitive Strengths & Weaknesses
Table 89. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 90. Thermo Fisher Scientific Major Business
Table 91. Thermo Fisher Scientific iPSC Therapy Product and Services
Table 92. Thermo Fisher Scientific iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Thermo Fisher Scientific Recent Developments/Updates
Table 94. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 95. Sartorius Basic Information, Manufacturing Base and Competitors
Table 96. Sartorius Major Business
Table 97. Sartorius iPSC Therapy Product and Services
Table 98. Sartorius iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Sartorius Recent Developments/Updates
Table 100. Sartorius Competitive Strengths & Weaknesses
Table 101. Bio-techne Basic Information, Manufacturing Base and Competitors
Table 102. Bio-techne Major Business
Table 103. Bio-techne iPSC Therapy Product and Services
Table 104. Bio-techne iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Bio-techne Recent Developments/Updates
Table 106. Bio-techne Competitive Strengths & Weaknesses
Table 107. Global Key Players of iPSC Therapy Upstream (Raw Materials)
Table 108. Global iPSC Therapy Typical Customers
LIST OF FIGURES
Figure 1. iPSC Therapy Picture
Figure 2. World iPSC Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World iPSC Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World iPSC Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World iPSC Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 13. iPSC Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World iPSC Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of iPSC Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for iPSC Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for iPSC Therapy Markets in 2025
Figure 27. United States VS China: iPSC Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: iPSC Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World iPSC Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World iPSC Therapy Market Size Market Share by Type in 2025
Figure 31. Human iPSCs
Figure 32. Mouse iPSCs
Figure 33. World iPSC Therapy Market Size Market Share by Type (2021-2032)
Figure 34. World iPSC Therapy Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 35. World iPSC Therapy Market Size Market Share by End User in 2025
Figure 36. Hospitals
Figure 37. Biotech Firms
Figure 38. Research Institutes
Figure 39. World iPSC Therapy Market Size Market Share by End User (2021-2032)
Figure 40. World iPSC Therapy Market Size by Cell Type, (USD Million), 2021 & 2025 & 2032
Figure 41. World iPSC Therapy Market Size Market Share by Cell Type in 2025
Figure 42. Neural Cells
Figure 43. Cardiac Cells
Figure 44. Retinal Cells
Figure 45. Immune Cells
Figure 46. World iPSC Therapy Market Size Market Share by Cell Type (2021-2032)
Figure 47. World iPSC Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World iPSC Therapy Market Size Market Share by Application in 2025
Figure 49. Academic Research
Figure 50. Drug Development and Discovery
Figure 51. Toxicity Screening
Figure 52. Regenerative Medicine
Figure 53. Others
Figure 54. World iPSC Therapy Market Size Market Share by Application (2021-2032)
Figure 55. iPSC Therapy Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. iPSC Therapy Picture
Figure 2. World iPSC Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World iPSC Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World iPSC Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World iPSC Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company iPSC Therapy Revenue (2021-2032) & (USD Million)
Figure 13. iPSC Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World iPSC Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of iPSC Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for iPSC Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for iPSC Therapy Markets in 2025
Figure 27. United States VS China: iPSC Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: iPSC Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World iPSC Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World iPSC Therapy Market Size Market Share by Type in 2025
Figure 31. Human iPSCs
Figure 32. Mouse iPSCs
Figure 33. World iPSC Therapy Market Size Market Share by Type (2021-2032)
Figure 34. World iPSC Therapy Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 35. World iPSC Therapy Market Size Market Share by End User in 2025
Figure 36. Hospitals
Figure 37. Biotech Firms
Figure 38. Research Institutes
Figure 39. World iPSC Therapy Market Size Market Share by End User (2021-2032)
Figure 40. World iPSC Therapy Market Size by Cell Type, (USD Million), 2021 & 2025 & 2032
Figure 41. World iPSC Therapy Market Size Market Share by Cell Type in 2025
Figure 42. Neural Cells
Figure 43. Cardiac Cells
Figure 44. Retinal Cells
Figure 45. Immune Cells
Figure 46. World iPSC Therapy Market Size Market Share by Cell Type (2021-2032)
Figure 47. World iPSC Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World iPSC Therapy Market Size Market Share by Application in 2025
Figure 49. Academic Research
Figure 50. Drug Development and Discovery
Figure 51. Toxicity Screening
Figure 52. Regenerative Medicine
Figure 53. Others
Figure 54. World iPSC Therapy Market Size Market Share by Application (2021-2032)
Figure 55. iPSC Therapy Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
